| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |